UK markets open in 2 hours 18 minutes

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
71.00+1.11 (+1.59%)
At close: 04:00PM EDT
70.80 -0.20 (-0.28%)
After hours: 07:15PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5443
Avg. Estimate0.781.034.445.6
Low estimate0.560.964.355.39
High estimate0.931.174.555.92
Year ago EPS2.281.426.094.44
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4454
Avg. Estimate27.92M33.19M137.68M160.73M
Low estimate23.38M29.93M134.3M153.8M
High estimate31.61M35.3M141.3M170M
Year ago sales43.98MN/A131.31M137.68M
Sales growth (year/est)-36.50%N/A4.80%16.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.890.640.610.66
Actual EPS2.281.421.021.38
Difference1.390.780.410.72
Surprise %156.20%121.90%67.20%109.10%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.781.034.445.6
7 days ago0.831.024.455.6
30 days ago0.831.024.455.6
60 days ago0.970.944.275.35
90 days ago0.851.024.285
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A1N/AN/A
Up last 30 daysN/A1N/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A1N/A
Growth estimatesLGNDIndustrySector(s)S&P 500
Current qtr.-65.80%N/AN/AN/A
Next qtr.-27.50%N/AN/AN/A
Current year-27.10%N/AN/AN/A
Next year26.10%N/AN/AN/A
Next 5 years (per annum)20.00%N/AN/AN/A
Past 5 years (per annum)9.76%N/AN/AN/A